Last updated: April 24, 2026
Who manufactures LYRICA (pregabalin) products?
LYRICA is the brand name for pregabalin, an active ingredient (API) with commercial supply sourced from multiple generic and branded production networks. In practice, “supplier” means one of three distinct parties: (1) API manufacturers (pregabalin), (2) finished-dose manufacturers (capsules/tablets/liquid where applicable), and (3) brand/legal product holders responsible for marketed packaging and regulatory listings.
Brand / originator marketing entity
- Pfizer Inc. is the originator and brand owner of LYRICA (pregabalin) in most key markets.
Finished-dose (drug product) manufacturing (typical network)
LYRICA finished dosage supply is typically produced through contract manufacturing and internal Pfizer sites that vary by country and market authorization holder. For investors and procurement teams, the most actionable supplier list is the regulatory listing of drug-product manufacturers for each market (EU, US, UK, etc.), because the “manufacturer of record” changes by authorization and packaging configuration.
What is the API supplier universe for pregabalin used in LYRICA-style products?
Pregabalin API is supplied by multiple global chemical manufacturers and contract API producers. The critical sourcing reality: generic pregabalin API supply often drives availability even for branded pregabalin products, through licensed manufacturing and dual-source qualification.
API supply categories
- Primary API manufacturers (multi-product fine-chemical plants producing pregabalin)
- Second-source API producers (qualified to supply under DMF/authorization networks)
- Licensed/contract API supply (producer-manufacturer relationships where the API plant differs from the finished-dose site)
Which country-market supplier lists matter most for procurement?
Supplier identification changes by market authorization, because regulatory filings name the drug product manufacturer and sometimes the API applicant and manufacturing sites. For procurement, the operational target is:
- Drug product manufacturer (capsule/tablet packaging site)
- API manufacturer (listed in regulatory dossiers such as DMF/CEP equivalents)
- Commercial distributor chains (who actually ships to hospitals/wholesalers)
What does an operational supplier list look like for LYRICA?
A procurement-ready supplier map should include:
1) Drug product supplier
- Manufacturer of LYRICA capsules (or other dosage forms in that market)
- Packaging and labeling site(s) responsible for commercial release
2) API supplier
- Pregabalin API manufacturer(s) listed in the regulatory dossier for that market
3) Wholesaler/distributor
- Approved national distribution channels for prescription drug logistics
Where do you find the legally binding supplier entries for LYRICA?
Use the following regulatory sources to extract named manufacturers:
- FDA drug labels and US regulatory product databases for the marketed product
- EMA (EU) product information and EPAR/Annex documentation for drug product manufacturer lists in EU markets
- MHRA (UK) and national agencies for post-Brexit product listings
- CEP/DMF-linked listings for API manufacturers (API sites can differ from finished-dose sites)
Key supplier takeaways for diligence
- Pfizer is the brand holder, but finished-dose manufacturing can be done by Pfizer sites and contract manufacturers by country.
- Pregabalin API is supplied by multiple chemical manufacturers globally; the correct “API supplier” list depends on the specific regulatory authorization for the market and dosage strength.
- Procurement should build a market-specific manufacturer map from regulator listings rather than relying on a single global supplier statement.
Key Takeaways
- LYRICA is pregabalin with Pfizer as brand holder; the supplier landscape is split between API producers, finished-dose manufacturers, and market distributors.
- The only procurement-grade supplier list is the market-specific manufacturer-of-record from regulator filings because the named supplier can change by country and dosage form.
- Pregabalin API is multi-sourced, so availability and lead-time risk often track API plant qualification rather than brand name branding.
FAQs
-
Is Pfizer the manufacturer of LYRICA in every country?
Pfizer is the brand holder; drug-product manufacturing can be performed by Pfizer sites and authorized contract manufacturers that vary by market.
-
Who supplies pregabalin API for LYRICA?
Pregabalin API is supplied by multiple qualified API manufacturers; the exact sites depend on the regulatory authorization for the market and strength.
-
What is the most reliable way to identify LYRICA suppliers?
Pull manufacturer-of-record entries from the relevant FDA/EMA/MHRA and label/regulatory documentation for each market.
-
Do API and finished-dose suppliers have to be the same company?
No. API plants and finished-dose manufacturers are often different and coordinated through dossier and authorization networks.
-
Why can suppliers differ between dosage strengths?
Different strengths can be manufactured on different lines or by different contract packagers, and market authorizations can vary by formulation and packaging configuration.
References
[1] Pfizer Inc. LYRICA (pregabalin) product and prescribing information (US). U.S. Food and Drug Administration.
[2] European Medicines Agency (EMA). Lyrica (pregabalin) product information and regulatory documentation for EU markets.
[3] UK Medicines and Healthcare products Regulatory Agency (MHRA). Lyrica (pregabalin) product listings and manufacturer information in UK submissions.
